Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asoprisnil Extension Study in Uterine Leiomyomata
NCT00156208Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Apr 2004
- Primary completion
- Dec 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of asoprisnil in uterine leiomyoma, sponsored by Abbott Laboratories. Started Apr 2004; status: completed.
02
Drugs
asoprisnil
03
Conditions
uterine leiomyoma
Beyond the preview
Go deeper on NCT00156208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156208.